Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant What is This Site Help Center Crisis
Powered By

Top 10 search results for "Verzenio" in Resources. To see all results and access other features, sign up for free.

Posts
Resources
Q&A
People
Groups
Treatments
Does Verzenio Cause Hair Loss?
... “I began Verzenio in October along with fulvestrant (Faslodex),” shared a MyBCTeam member. “I started noticing hair loss (head, eyebrows, eyelashes, and body hair) in March. The thinning is now pretty significant.”Hair loss and thinning are possible side effects of fulvestrant and many other breast cancer medications. ...
Does Verzenio Cause Hair Loss?
... “I began Verzenio in October along with fulvestrant (Faslodex),” shared a MyBCTeam member. “I started noticing hair loss (head, eyebrows, eyelashes, and body hair) in March. The thinning is now pretty significant.”Hair loss and thinning are possible side effects of fulvestrant and many other breast cancer medications. ...
Chemotherapy for Metastatic Breast Cancer: What To Expect
... Komen Verzenio (Abemaciclib): What To Expect, Side Effects, and More — Breastcancer.org Targeted Drug Therapy for Breast Cancer — American Cancer Society Triple-Negative Breast Cancer — American Cancer Society Treatment of Triple-Negative Breast Cancer — American Cancer Society Chemotherapy To Treat Cancer — National Cancer Institute ...
Chemotherapy for Metastatic Breast Cancer: What To Expect
... Komen Verzenio (Abemaciclib): What To Expect, Side Effects, and More — Breastcancer.org Targeted Drug Therapy for Breast Cancer — American Cancer Society Triple-Negative Breast Cancer — American Cancer Society Treatment of Triple-Negative Breast Cancer — American Cancer Society Chemotherapy To Treat Cancer — National Cancer Institute ...
What Is Progression-Free Survival in Metastatic Breast Cancer?
... Abemaciclib (Verzenio) may be used as a first-line treatment for some cases of MBC, or it may be combined with the hormone therapy fulvestrant (Faslodex) if cancer has progressed despite other treatments.The overall goals of treating MBC are to improve your quality of life and keep metastatic disease progression at bay. ...
What Is Progression-Free Survival in Metastatic Breast Cancer?
... Abemaciclib (Verzenio) may be used as a first-line treatment for some cases of MBC, or it may be combined with the hormone therapy fulvestrant (Faslodex) if cancer has progressed despite other treatments.The overall goals of treating MBC are to improve your quality of life and keep metastatic disease progression at bay. ...
Targeted Therapy for Breast Cancer: Types, Side Effects, and More
... Some of the kinases that can be targeted in breast cancer include HER2, CDK4/6, mTOR, AKT, and PI3K.Examples of kinase inhibitors that target HER2 include: Lapatinib (Tykerb) Neratinib (Nerlynx) Tucatinib (Tukysa) CDK4/6 inhibitors include: Abemaciclib (Verzenio) Palbociclib (Ibrance) Ribociclib (Kisqali) Everolimus (Afinitor) is an mTOR inhibitor. ...
Targeted Therapy for Breast Cancer: Types, Side Effects, and More
... Some of the kinases that can be targeted in breast cancer include HER2, CDK4/6, mTOR, AKT, and PI3K.Examples of kinase inhibitors that target HER2 include: Lapatinib (Tykerb) Neratinib (Nerlynx) Tucatinib (Tukysa) CDK4/6 inhibitors include: Abemaciclib (Verzenio) Palbociclib (Ibrance) Ribociclib (Kisqali) Everolimus (Afinitor) is an mTOR inhibitor. ...
Stage 2 Breast Cancer: Treatment and Prognosis
... In stage 2 breast cancer, targeted therapy and immunotherapy options may include: Abemaciclib (Verzenio) Ado-trastuzumab emtansine (Kadcyla) Neratinib (Nerlynx) Olaparib (Lynparza) Pertuzumab (Perjeta) Ribociclib (Kisqali) Trastuzumab (Herceptin) Depending on details about your breast cancer cells, hormone therapy, targeted therapy, or immunotherapy ...
Stage 2 Breast Cancer: Treatment and Prognosis
... In stage 2 breast cancer, targeted therapy and immunotherapy options may include: Abemaciclib (Verzenio) Ado-trastuzumab emtansine (Kadcyla) Neratinib (Nerlynx) Olaparib (Lynparza) Pertuzumab (Perjeta) Ribociclib (Kisqali) Trastuzumab (Herceptin) Depending on details about your breast cancer cells, hormone therapy, targeted therapy, or immunotherapy ...
Navigating Treatments and Prognosis for Stage 3 Breast Cancer
... In stage 3 breast cancer, targeted therapy options may include: Abemaciclib (Verzenio) Ado-trastuzumab emtansine (Kadcyla) Neratinib (Nerlynx) Olaparib (Lynparza) Pertuzumab (Perjeta) Ribociclib (Kisqali) Trastuzumab (Herceptin) Treating Triple-Negative Breast CancerIf breast cancer cells are negative for ER, PR, and HER2, the cancer is called triple-negative ...
Navigating Treatments and Prognosis for Stage 3 Breast Cancer
... In stage 3 breast cancer, targeted therapy options may include: Abemaciclib (Verzenio) Ado-trastuzumab emtansine (Kadcyla) Neratinib (Nerlynx) Olaparib (Lynparza) Pertuzumab (Perjeta) Ribociclib (Kisqali) Trastuzumab (Herceptin) Treating Triple-Negative Breast CancerIf breast cancer cells are negative for ER, PR, and HER2, the cancer is called triple-negative ...
Breast Cancer Spreading to the Bones: Pain and 5 Other Symptoms (Plus How To Treat)
... CDK4/6 inhibitors include palbociclib, ribociclib (Kisqali), and abemaciclib (Verzenio).There have also been advances in treating metastatic triple-negative breast cancer (TNBC). Pembrolizumab (Keytruda) combined with chemotherapy is FDA-approved as a first-line treatment for PD-L1-positive metastatic TNBC. ...
Breast Cancer Spreading to the Bones: Pain and 5 Other Symptoms (Plus How To Treat)
... CDK4/6 inhibitors include palbociclib, ribociclib (Kisqali), and abemaciclib (Verzenio).There have also been advances in treating metastatic triple-negative breast cancer (TNBC). Pembrolizumab (Keytruda) combined with chemotherapy is FDA-approved as a first-line treatment for PD-L1-positive metastatic TNBC. ...
New Treatments for Metastatic Breast Cancer: Extending Life
... Abemaciclib (Verzenio) — Abemaciclib prevented cancer progression for seven months longer than the control treatment, per the FDA. Ribociclib (Kisqali) — Seventy percent of people taking ribociclib were alive after 42 months, compared to 46 percent of people taking hormone therapy alone, according to the National Cancer Institute. ...
New Treatments for Metastatic Breast Cancer: Extending Life
... Abemaciclib (Verzenio) — Abemaciclib prevented cancer progression for seven months longer than the control treatment, per the FDA. Ribociclib (Kisqali) — Seventy percent of people taking ribociclib were alive after 42 months, compared to 46 percent of people taking hormone therapy alone, according to the National Cancer Institute. ...
Back Pain After Chemo: Can Chemo Cause Sciatica?
... These hormonal therapies are sometimes combined with cyclin-dependent kinase 4/6 inhibitors such as abemaciclib (Verzenio), palbociclib (Ibrance), and ribociclib (Kisqali). Aromatase inhibitors are a type of hormonal therapy that can cause stiff joints and sore, weak muscles. ...
Back Pain After Chemo: Can Chemo Cause Sciatica?
... These hormonal therapies are sometimes combined with cyclin-dependent kinase 4/6 inhibitors such as abemaciclib (Verzenio), palbociclib (Ibrance), and ribociclib (Kisqali). Aromatase inhibitors are a type of hormonal therapy that can cause stiff joints and sore, weak muscles. ...
New Treatments for Metastatic Breast Cancer
... Verzenio (abemaciclib) was the first CDK4/6 inhibitor approved as a stand-alone therapy for MBC treatment in 2017. Other FDA-approved CDK4/6 inhibitors are Ibrance (palbociclib) and Kisqali (ribociclib). ...
New Treatments for Metastatic Breast Cancer
... Verzenio (abemaciclib) was the first CDK4/6 inhibitor approved as a stand-alone therapy for MBC treatment in 2017. Other FDA-approved CDK4/6 inhibitors are Ibrance (palbociclib) and Kisqali (ribociclib). ...